Cape Coral
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
12- Orthopaedic Surgery
- 12
How orthopedic groups typically vet a new biologics supplier
Orthopedic practices and ambulatory surgery centers that add a new biologics line generally start with a documentation review rather than a sales conversation. Practice managers and medical directors ask for the same category of records regardless of city: lot-specific certificates of analysis, donor eligibility and screening summaries, and sterility testing results from a third-party laboratory.
Precision Biologics provides these records on request to verified accounts. Each tissue lot carries its own identifier, and testing results are tied to that lot rather than to a general product claim.
- Certificate of analysis by lot
- Donor eligibility and screening summary
- Third-party sterility testing results
- Lot release record
NPI-verified accounts for practices and surgery centers
Opening an account requires a National Provider Identifier, and orders are restricted to licensed professionals. Multi-physician groups and surgery centers in Cape Coral typically designate one administrator to handle procurement credentialing across several providers, then route individual orders through that verified account.
Verification is a one-time step; it does not substitute for the clinic's own internal credentialing or purchasing policy.
Cold-chain shipping and receiving
Cryopreserved Wharton's jelly products are stored at -80 degrees Celsius and shipped overnight on dry ice in validated containers. Lyophilized formats do not require cryogenic storage and are handled differently on receipt. Clinics in Cape Coral should confirm with their shipping and receiving staff which format they are ordering before the first delivery arrives, since cold-chain and shelf-stable products follow different intake procedures.
Confirming regulatory posture before purchasing
Whether a specific intended use fits within the applicable HCT/P framework is a determination for the clinic and its own counsel, not something Precision Biologics advises on. Florida orthopedic groups should also verify current requirements directly with the Florida Board of Medicine. Florida's SB 1768, effective July 2025, permits physicians to use certain non-FDA-approved stem cell therapies in orthopedics, wound care and pain management with informed consent and disclosure requirements, but it does not change federal FDA rules that apply to any specific product.
These products are not FDA approved or licensed for any disease or condition. Account managers are available for peer-to-peer conversations about documentation, not clinical guidance.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does Precision Biologics sell directly to patients or the public in Cape Coral?+
No. Accounts are limited to licensed physicians and clinics operating under physician supervision, and account verification requires a National Provider Identifier.
What documentation should our surgery center request before adding a new biologics line?+
Ask for the lot-specific certificate of analysis, donor eligibility summary, third-party sterility testing results and lot release record. These are available to verified accounts on request.
Are the Wharton's jelly products FDA approved for orthopedic use?+
No product discussed here is FDA approved or licensed for any disease or condition. Whether a specific intended use qualifies under the applicable HCT/P framework is a determination for your practice and its counsel.